Cargando…
microRNAs Shape Myeloid Cell-Mediated Resistance to Cancer Immunotherapy
Immunotherapy with immune checkpoint inhibitors can achieve long-term tumor control in subsets of patients. However, its effect can be blunted by myeloid-induced resistance mechanisms. Myeloid cells are highly plastic and physiologically devoted to wound healing and to immune homeostasis maintenance...
Autores principales: | Daveri, Elena, Vergani, Elisabetta, Shahaj, Eriomina, Bergamaschi, Laura, La Magra, Stefano, Dosi, Michela, Castelli, Chiara, Rodolfo, Monica, Rivoltini, Licia, Vallacchi, Viviana, Huber, Veronica |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7387687/ https://www.ncbi.nlm.nih.gov/pubmed/32793185 http://dx.doi.org/10.3389/fimmu.2020.01214 |
Ejemplares similares
-
Targeting Immune Regulatory Networks to Counteract Immune Suppression in Cancer
por: Camisaschi, Chiara, et al.
Publicado: (2016) -
3D models for melanoma γδ T cell‐based immunotherapy
por: Huber, Veronica, et al.
Publicado: (2022) -
3D tumor explant as a novel platform to investigate therapeutic pathways and predictive biomarkers in cancer patients
por: Rodolfo, Monica, et al.
Publicado: (2022) -
miR-146a-5p impairs melanoma resistance to kinase inhibitors by targeting COX2 and regulating NFkB-mediated inflammatory mediators
por: Vergani, Elisabetta, et al.
Publicado: (2020) -
Overcoming melanoma resistance to vemurafenib by targeting CCL2-induced miR-34a, miR-100 and miR-125b
por: Vergani, Elisabetta, et al.
Publicado: (2015)